Related references
Note: Only part of the references are listed.Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
Lisa A. Carey et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Impact of Neoadjuvant Chemotherapy in Stage II-III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates Surgical Results From CALGB 40603 (Alliance)
Mehra Golshan et al.
ANNALS OF SURGERY (2015)
Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer
Dennis Holmes et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude
Marc Debled et al.
EUROPEAN JOURNAL OF CANCER (2015)
Surgical Patterns of Care in Patients with Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy and Breast Magnetic Resonance Imaging: Results of a Secondary Analysis of TBCRC 017
Kandace P. McGuire et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial
C. Criscitiello et al.
ANNALS OF ONCOLOGY (2014)
Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)
Elizabeth L. Cureton et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Influences on decision for mastectomy in patients eligible for breast conserving surgery
E. E. Rippy et al.
BREAST (2014)
Surgical treatment of primary breast cancer in the neoadjuvant setting
S. Kuemmel et al.
BRITISH JOURNAL OF SURGERY (2014)
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Gunter von Minckwitz et al.
LANCET ONCOLOGY (2014)
Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
Abigail S. Caudle et al.
BREAST CANCER RESEARCH (2012)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis
D Mauri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
JA van der Hage et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
